Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

[1]  M. Grady,et al.  Clinically silent somatotroph adenomas are common , 2011, European journal of endocrinology.

[2]  S. Melmed,et al.  Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. , 2011, The Journal of clinical endocrinology and metabolism.

[3]  V. Montori,et al.  Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline , 2011, The Journal of clinical endocrinology and metabolism.

[4]  Victor M Montori,et al.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  J. Lachuer,et al.  Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease. , 2010, European journal of endocrinology.

[6]  Sun Wook Cho,et al.  Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas , 2010, Clinical endocrinology.

[7]  S. Melmed,et al.  Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes , 2010, Hormones & cancer.

[8]  Alberto Fernández,et al.  Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) , 2010, Clinical endocrinology.

[9]  S. Melmed.  Acromegaly pathogenesis and treatment. , 2009, The Journal of clinical investigation.

[10]  Z. Qian,et al.  Clinicopathological Characterization of TSH-Producing Adenomas: Special Reference to TSH-immunoreactive but Clinically Non-functioning Adenomas , 2009, Endocrine pathology.

[11]  B. Scheithauer,et al.  Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience , 2009, Clinical endocrinology.

[12]  P. Sőnksen,et al.  Pituitary incidentaloma , 2008, Clinical endocrinology.

[13]  M. Castro,et al.  Thyroid-stimulating hormone pituitary adenomas. , 2008, Journal of neurosurgery.

[14]  J. Drouin,et al.  Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin. , 2008, Molecular endocrinology.

[15]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[16]  A. Levy.  Molecular and trophic mechanisms of tumorigenesis. , 2008, Endocrinology and metabolism clinics of North America.

[17]  T. Yoshimoto,et al.  Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. , 2007, European journal of endocrinology.

[18]  D. Capper,et al.  Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[19]  T. Sano,et al.  A STUDY OF THE CORRELATION BETWEEN MORPHOLOGICAL FINDINGS AND BIOLOGICAL ACTIVITIES IN CLINICALLY NONFUNCTIONING PITUITARY ADENOMAS , 2007, Neurosurgery.

[20]  Michael Buchfelder,et al.  Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. , 2007, European journal of endocrinology.

[21]  H. Reid,et al.  Silent growth hormone secreting pituitary adenomas: IGF-1 is not sufficient to exclude growth hormone excess , 2007, Annals of clinical biochemistry.

[22]  S. Melmed.  Medical progress: Acromegaly. , 2006, The New England journal of medicine.

[23]  A. Beckers,et al.  High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  B. Scheithauer,et al.  Pathobiology of Pituitary Adenomas and Carcinomas , 2006, Neurosurgery.

[25]  I. Vajtai,et al.  Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review. , 2006, Pathology, research and practice.

[26]  W. Saeger,et al.  Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. , 2006, European journal of endocrinology.

[27]  A. Barkan,et al.  Clinically silent somatotropinomas may be biochemically active. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  J. Jang,et al.  Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors. , 2005, Journal of neurosurgery. Spine.

[29]  J. Ahlquist,et al.  A spectrum of behaviour in silent corticotroph pituitary adenomas , 2005, British journal of neurosurgery.

[30]  K. Kovacs,et al.  Silent Adenoma Subtype 3 of the Pituitary—Immunohistochemical and Ultrastructural Classification: A Review of 29 Cases , 2005, Ultrastructural pathology.

[31]  T. Sano,et al.  Co-localization of honeycomb golgi and ACTH granules in a giant ACTH-producing pituitary adenoma , 2005, Endocrine pathology.

[32]  P. Chanson,et al.  Non-functioning pituitary adenomas. , 2005, Journal of endocrinological investigation.

[33]  G. Stalldecker,et al.  Retrospective Multicentric Study of Pituitary Incidentalomas , 2005, Pituitary.

[34]  W. Woodmansee,et al.  Silent corticotroph adenomas: further clinical and pathological observations. , 2004, Human pathology.

[35]  E. Laws,et al.  Double Pituitary Lesions in Three Patients with Cushing's Disease , 2000, Pituitary.

[36]  T. Kawase,et al.  Morphological Characterization and Subtyping of Silent Somatotroph Adenomas , 1999, Pituitary.

[37]  T. Yokoyama,et al.  Significance of Absent Prohormone Convertase 1/3 in Inducing Clinically Silent Corticotroph Pituitary Adenoma of Subtype I—Immunohistochemical Study , 2004, Pituitary.

[38]  S. Melmed.  Mechanisms for pituitary tumorigenesis: the plastic pituitary. , 2003, The Journal of clinical investigation.

[39]  D. Okonkwo,et al.  Clinical Characteristics of Silent Corticotrophic Adenomas and Creation of an Internet-accessible Database to Facilitate Their Multi-institutional Study , 2003, Neurosurgery.

[40]  Takashi Suzuki,et al.  Nuclear receptor DAX‐1 in human common epithelial ovarian carcinoma: An independent prognostic factor of clinical outcome , 2003, Cancer science.

[41]  A. Teramoto,et al.  A survey of pituitary incidentaloma in Japan. , 2003, European journal of endocrinology.

[42]  D. Figarella-Branger,et al.  Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. , 2003, The Journal of clinical endocrinology and metabolism.

[43]  Alan Morgan,et al.  Secretory granule exocytosis. , 2003, Physiological reviews.

[44]  J. Wass,et al.  Non‐functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently , 2003, Clinical endocrinology.

[45]  Z. Qian,et al.  “Honeycomb Golgi” in pituitary adenomas: Not a marker of gonadotroph adenomas , 2003, Endocrine pathology.

[46]  K. Yamamura,et al.  Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay. , 2002, Endocrine journal.

[47]  T. Sano,et al.  Pituitary adenoma with “Honeycomb golgi” appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical cushing disease , 2002, Endocrine pathology.

[48]  T. Kameya,et al.  Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: Difference among functioning, silent, and other nonfunctioning adenomas , 2002, Endocrine pathology.

[49]  J. Kuratsu,et al.  A case of non‐functioning pituitary adenoma with Cushing's syndrome upon recurrence , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.

[50]  S. Takekoshi,et al.  Expression of Neuro D1 in Human Normal Pituitaries and Pituitary Adenomas , 2001, Modern Pathology.

[51]  M. Rosenfeld,et al.  Tbx19, a tissue-selective regulator of POMC gene expression , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Drouin,et al.  A Pituitary Cell-Restricted T Box Factor, Tpit, Activates POMC Transcription in Cooperation with Pitx Homeoproteins , 2001, Cell.

[53]  B. Scheithauer,et al.  Clinically Silent Corticotroph Tumors of the Pituitary Gland , 2000, Neurosurgery.

[54]  A. Matsuno,et al.  Detection of a silent pituitary somatotroph adenoma in a patient with amenorrhea and/or galactorrhea: paradoxical response of GH in TRH or GnRH provocation test. , 2000, Endocrine journal.

[55]  S. Camper,et al.  Genealogy of the Anterior Pituitary Gland: Tracing a Family Tree , 1999, Trends in Endocrinology & Metabolism.

[56]  T. Yanase,et al.  Dax-1 as one of the target genes of Ad4BP/SF-1. , 1999, Molecular endocrinology.

[57]  T. Tomita,et al.  Pituitary adenomas and granular cell tumors. Incidence, cell type, and location of tumor in 100 pituitary glands at autopsy. , 1999, American journal of clinical pathology.

[58]  J. Trouillas,et al.  Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. , 1999, European journal of endocrinology.

[59]  K. Kovacs,et al.  Pars intermedia of the human pituitary revisited: Morphologic aspects and frequency of hyperplasia of POMC-peptide immunoreactive cells , 1999 .

[60]  S. Melmed.  Pathogenesis of pituitary tumors. , 1999, Endocrinology and metabolism clinics of North America.

[61]  T. Tomita,et al.  PITUITARY ADENOMAS AND GRANULAR CELL TUMORS , 1999 .

[62]  K. Kandror,et al.  Exploring Protein Interactions , 1998, Trends in endocrinology and metabolism.

[63]  D. Redelmeier,et al.  Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing's disease. , 1998, The Journal of clinical endocrinology and metabolism.

[64]  K. Ohe,et al.  Expression of an orphan nuclear receptor DAX‐1 in human pituitary adenomas , 1998, Clinical endocrinology.

[65]  D. Lüdecke,et al.  Clinically nonsecreting pituitary adenomas in childhood and adolescence. , 1998, Neurosurgery.

[66]  G. Kontogeorgos,et al.  Triple Pituitary Adenoma in Cushing's Disease: Case Report , 1998, Acta Neurochirurgica.

[67]  B. Biller,et al.  Clinical and biochemical evaluation of Cushing's syndrome. , 1997, Endocrinology and metabolism clinics of North America.

[68]  G. Poulin,et al.  NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene , 1997, Molecular and cellular biology.

[69]  T. Yoshimoto,et al.  Clinico‐pathological study of Cushing's disease with large pituitary adenoma , 1997, Clinical endocrinology.

[70]  T. Sano,et al.  A case of nonfunctioning pituitary adenoma resembling so-called silent corticotroph adenoma. , 1997, Endocrine journal.

[71]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[72]  B. Scheithauer,et al.  Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases. , 1996, Mayo Clinic proceedings.

[73]  S. Asa,et al.  The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. , 1996, The Journal of clinical endocrinology and metabolism.

[74]  A. Teramoto,et al.  Incidental pituitary lesions in 1,000 unselected autopsy specimens. , 1994, Radiology.

[75]  S. Yamada,et al.  Histologic and immunohistochemical study of clinically non‐functioning pituitary adenomas , 1994, Pathology international.

[76]  B. Weintraub,et al.  An AP-1-like factor and the pituitary-specific factor Pit-1 are both necessary to mediate hormonal induction of human thyrotropin beta gene expression. , 1993, The Journal of biological chemistry.

[77]  T. Sano,et al.  Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. , 1993, The Journal of clinical endocrinology and metabolism.

[78]  S. Asa,et al.  Clinically Non-Functioning Human Pituitary Adenomas , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[79]  G. Sassolas,et al.  Somatotropic adenomas without acromegaly. , 1991, Pathology, research and practice.

[80]  K. Franssila,et al.  Hyalinizing trabecular adenoma: A misnomer for a peculiar tumor of the thyroid gland , 1991, Endocrine Pathology.

[81]  M. Rosenfeld.  POU-domain transcription factors: pou-er-ful developmental regulators. , 1991, Genes & development.

[82]  J. Tourniaire.  [The so-called silent corticotropic pituitary adenoma]. , 1991, Presse medicale.

[83]  B. Scheithauer,et al.  Multiple adenomas of the human pituitary. A retrospective autopsy study with clinical implications. , 1991, Journal of neurosurgery.

[84]  A. Beckers,et al.  Thyrotropin-secreting pituitary adenomas: report of seven cases. , 1991, The Journal of clinical endocrinology and metabolism.

[85]  K. Kovacs,et al.  Sex-linked ultrastructural dichotomy of gonadotroph adenomas of the human pituitary: an electron microscopic analysis of 145 tumors. , 1990, Ultrastructural pathology.

[86]  W. Saeger,et al.  The 'incidentaloma' of the pituitary gland. Is neurosurgery required? , 1990, JAMA.

[87]  S. Asa,et al.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. , 1989, The American journal of pathology.

[88]  J. D. Neill,et al.  14 – Detection and Measurement of Secretion from Individual Neuroendocrine Cells Using a Reverse Hemolytic Plaque Assay , 1989 .

[89]  S. Asa,et al.  Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay. , 1989, The Journal of clinical endocrinology and metabolism.

[90]  G. Sassolas,et al.  The TSH secretion in the human pituitary adenomas. , 1988, Pathology, research and practice.

[91]  H. Heshmati,et al.  The immunocytochemical heterogeneity of silent pituitary adenomas. , 1988, Acta endocrinologica.

[92]  B. Scheithauer,et al.  A novel type of pituitary adenoma: morphological features and clinical correlations. , 1988, The Journal of clinical endocrinology and metabolism.

[93]  R. Albrechtsen,et al.  Heterogeneity of secretory granules of silent pituitary adenomas. , 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[94]  F. Brucker-Davis,et al.  Thyrotropin-secreting pituitary tumors. , 1996, Endocrinology and metabolism clinics of North America.

[95]  K. Kovacs,et al.  Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. , 1987, Journal of Neurosurgery.

[96]  P. Black,et al.  Hormone production in clinically nonfunctioning pituitary adenomas. , 1987, Journal of neurosurgery.

[97]  K. Kangawa,et al.  High plasma concentrations of human atrial natriuretic polypeptide in aged men. , 1987, The Journal of clinical endocrinology and metabolism.

[98]  H. Lodish.  Molecular Cell Biology , 1986 .

[99]  J. D. Neill,et al.  Detection and measurement of secretion from individual neuroendocrine cells using a reverse hemolytic plaque assay. , 1986, Methods in enzymology.

[100]  K. Kovacs,et al.  Gonadotroph adenomas of the human pituitary: sex-related fine-structural dichotomy. A histologic, immunocytochemical, and electron-microscopic study of 30 tumors. , 1984, The American journal of pathology.

[101]  B. Scheithauer,et al.  Pituitary adenomas producing growth hormone, prolactin, and one or more glycoprotein hormones: a histologic, immunohistochemical, and ultrastructural study of four surgically removed tumors. , 1983, Ultrastructural pathology.

[102]  E. E. Smith,et al.  Incidental pituitary adenomas: a retrospective study. , 1982, Surgery.

[103]  H. Lisser,et al.  Acromegaly: A Consideration of Its Course and Treatment Report of Four Cases with Autopsies , 1942 .

[104]  A. U. Desjardins.  The Radiation Treatment of Hodgkin's Disease With Particular Reference to Mediastinal Involvement1 , 1923 .

[105]  Mohamad Maghniea,et al.  The Pituitary , 1919, The Indian Medical Gazette.